LANDMARC Study: a Study With Focus on Aorta Ascendens
Assessment of the pathophysioLogical bAsis of Local Tissue compliaNce Using augmenteD iMAging Techniques to Identify Regional Flow dynamiCs (LANDMARC): a Study With Focus on Aorta Ascendens
1 other identifier
observational
65
1 country
1
Brief Summary
Rationale: Aortic diameter is currently used as a gold standard in international guidelines for prediction of aorta pathology (aortic aneurysm and aortic dissection). However, aortic diameter has proven to be insufficiently accurate for making decisions about well-timed preventive interventions. The LANDMARC study will take place in line with the FIBAA-bank ('Correlatie tussen cardiovasculaire FIBroseringsgraad en Aorta elongatie, dilatatie en Atria dilatatie (FIBAA-bank): een biobank \& databank onderzoek met focus op aorta en atria' (METC-number 2022-3164)), and aims to reveal the undiscovered relationship between WSS (wall shear stress) values and aortic strain. In combination with data from the FIBAA-bank, the LANDMARC study will provide more accurate information for future risk stratification models for cardiovascular pathology (with focus on aortic disease). Objectives: Primary objective: indication of the association between WSS (peak WSS and WSS gradient) (through 4D-flow MR and CT) and aortic strain. Secondary objective: indication of the association between (hemo)dynamic processes within the body (aortic elongation/aortic strain) and (patho-)physiological changes (degree of cardiovascular tissue fibrosis).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2022
CompletedStudy Start
First participant enrolled
December 15, 2022
CompletedFirst Posted
Study publicly available on registry
December 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 15, 2025
CompletedDecember 19, 2022
November 1, 2022
1 year
November 22, 2022
December 16, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Indication of the association between WSS (peak WSS and WSS gradient) (through 4D-flow MR and CT) and aortic strain.
Previous research described the importance of aortic strain for the prediction of aortic disease. By linking this information to information that can be obtained via advanced imaging techniques, future predictions about aortic disease can be made more easily and will be more accurate.
Until 12 months postoperative
Secondary Outcomes (1)
Indication of the association between (hemo)dynamic processes within the body (aortic elongation/aortic strain) and (patho-)physiological changes (degree of cardiovascular tissue fibrosis).
Until 12 months postoperative
Interventions
4D-flow MR and CT-scan after cardiac surgery (until 12 months afterwards), for the purpose of obtaining more precise data on (hemo)dynamic processes within the cardiovascular system, in combination with data extraction from the established biobank and databank (FIBAA-bank).
Eligibility Criteria
The study population of the LANDMARC study will consist of patients who underwent open heart surgery and have participated in FIBAA-bank.
You may qualify if:
- years and older
- Able to understand the trial and provide informed consent
- Patients who have participated in the FIBAA-bank
You may not qualify if:
- Patients with abnormal congenital cardiothoracic anatomy, with exception of presence of a bicuspid aortic valve
- Patients with history of chemotherapy, or radiotherapy within thoracic region
- Patients with an age \>80 years
- Patients with a weight \>120 kg
- Patients with a contra-indication for MRI according to the MUMC+ ODIN protocol nr. 004952
- Patients with impaired renal function (GFR \<30)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MaastrichtUMC
Maastricht, Limburg, 6229 HX, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2022
First Posted
December 19, 2022
Study Start
December 15, 2022
Primary Completion
December 15, 2023
Study Completion
January 15, 2025
Last Updated
December 19, 2022
Record last verified: 2022-11